Page last updated: 2024-11-05

nikethamide and Kernicterus

nikethamide has been researched along with Kernicterus in 1 studies

Nikethamide: A central nervous system stimulant. It was formerly used in the treatment of barbiturate overdose but is now considered to be of no value for such purposes and may be dangerous. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1229)

Kernicterus: A term used pathologically to describe BILIRUBIN staining of the BASAL GANGLIA; BRAIN STEM; and CEREBELLUM and clinically to describe a syndrome associated with HYPERBILIRUBINEMIA. Clinical features include athetosis, MUSCLE SPASTICITY or hypotonia, impaired vertical gaze, and DEAFNESS. Nonconjugated bilirubin enters the brain and acts as a neurotoxin, often in association with conditions that impair the BLOOD-BRAIN BARRIER (e.g., SEPSIS). This condition occurs primarily in neonates (INFANT, NEWBORN), but may rarely occur in adults. (Menkes, Textbook of Child Neurology, 5th ed, p613)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ertel, IJ1
Newton, WA1

Other Studies

1 other study available for nikethamide and Kernicterus

ArticleYear
Therapy in congenital hyperbilirubinemia: phenobarbital and diethylnicotinamide.
    Pediatrics, 1969, Volume: 44, Issue:1

    Topics: Bilirubin; Child; Child, Preschool; Female; Humans; Hyperbilirubinemia, Hereditary; Infant; Infant,

1969